Is Moderna, Inc. overvalued?

Moderna, Inc. (MRNA) — key valuation metrics and fundamentals.

No verdict

Price

$67.27

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$26.69B

Dividend yield

0.0%

Return on equity

-32.6%

Sector

Healthcare

Fair value compares MRNA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks